Prevention of vertical HIV transmission: Additive protective effect of elective Cesarean section and zidovudine prophylaxis

AIDS

Volumn 12, Issue 2, 1998, Pages 205-210

  Kind, Christian ^a   Rudin, Christoph ^b   Siegrist, Claire Anne ^c   Wyler, Claire Anne ^c   Biedermann, Kurt ^d   Lauper, Urs ^e   Irion, Olivier ^f   Schüpbach, Jörg ^g   Nadal, David ^h  

^a Division of Neonatology   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

^d Womens Hospital   (Switzerland)

^e UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Cesarean section; Epidemiology; Vertical transmission; Zidovudine

Indexed keywords

ZIDOVUDINE;

ADULT; ARTICLE; CESAREAN SECTION; CHILD; COHORT ANALYSIS; DELIVERY; ELECTIVE SURGERY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LABOR; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWITZERLAND; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; ANTI-HIV AGENTS; CESAREAN SECTION; CHILD, PRESCHOOL; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL MONITORING; HIV INFECTIONS; HUMANS; INFANT; OBSTETRICAL FORCEPS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RISK FACTORS; SWITZERLAND; VACUUM EXTRACTION, OBSTETRICAL; ZIDOVUDINE;

EID: 0032556960     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199802000-00011     Document Type: Article

References (16)

1. The European Collaborative Study: Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996, 10:1675-1681.
2. Kuhn L, Bobat R, Coutsoudis A, et al.: Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:478-483.
3. Mandelbrot L, Mayaux MJ, Bongain A, et al.: Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996, 175:661-667.
4. Kind C, Paediatric AIDS Group of Switzerland: Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Eur J Pediatr 1995, 154:542-545.
5. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
6. Kind C, Brändle B, Wyler C-A, et al.: Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Eur J Pediatr 1992, 151:442-448.
7. Schüpbach J, Böni J, Tomasik Z, et al.: Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. J Infect Dis 1994, 170:318-324.
8. Schüpbach J, Flepp M, Pontelli D, Tomasik Z, Lüthy R, Böni J: Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 1996, 10:1085-1090.
9. Centers for Disease Control: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 1986, 35:334-339.
10. Siegrist C-A, Yerly S, Kaiser L, Wyler C-A, Perrin L: Mother to child transmission of zidovudine resistant HIV-1. Lancet 1994, 344:1771-1772.
11. Scarlatti G: Paediatric HIV infection. Lancet 1996, 348:863-868.
12. The European Collaborative Study: Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994, 343:1464-1467.
13. Dunn D, Newell ML, Mayaux MJ, et al.: Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immune Defic Syndr 1994, 7:1064-1066.
14. Frenkel LM, Wagner LE, Demeter LM, et al.: Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin Infect Dis 1995, 20:1321-1326.
15. Dickover RE, Garratty EM, Herman SA, et al.: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA 1996, 275:599-605.
16. Sperling RS, Shapiro DE, Coombs RW, et al.: Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996, 335:1621-1629.